BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 37422839)

  • 1. Oncologic Significance of Therapeutic Delays in Patients With Oral Cavity Cancer.
    Dayan GS; Bahig H; Johnson-Obaseki S; Eskander A; Hong X; Chandarana S; de Almeida JR; Nichols AC; Hier M; Belzile M; Gaudet M; Dort J; Matthews TW; Hart R; Goldstein DP; Yao CMKL; Hosni A; MacNeil D; Fowler J; Higgins K; Khalil C; Khoury M; Mlynarek AM; Morand G; Sultanem K; Maniakas A; Ayad T; Christopoulos A
    JAMA Otolaryngol Head Neck Surg; 2023 Nov; 149(11):961-969. PubMed ID: 37422839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of prolonged treatment time intervals in oral cavity cancer.
    Dayan G; Bahig H; Fortin B; Filion É; Nguyen-Tan PF; O'Sullivan B; Charpentier D; Soulières D; Gologan O; Nelson K; Létourneau L; Schmittbuhl M; Ayad T; Bissada E; Guertin L; Tabet P; Christopoulos A
    Oral Oncol; 2023 Dec; 147():106622. PubMed ID: 37948896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in Survival With Surgery and Postoperative Radiotherapy Compared With Definitive Chemoradiotherapy for Oral Cavity Cancer: A National Cancer Database Analysis.
    Spiotto MT; Jefferson G; Wenig B; Markiewicz M; Weichselbaum RR; Koshy M
    JAMA Otolaryngol Head Neck Surg; 2017 Jul; 143(7):691-699. PubMed ID: 28426848
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative Radiotherapy and Survival in Oral Cavity Squamous Cell Carcinoma With Mandibulectomy.
    Harley RJ; Iheagwara UK; Faraji F; Sridharan S; Kubik MW
    JAMA Otolaryngol Head Neck Surg; 2024 Mar; 150(3):233-239. PubMed ID: 38300601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment delays in oral cavity squamous cell carcinoma and association with survival.
    Fujiwara RJ; Judson BL; Yarbrough WG; Husain Z; Mehra S
    Head Neck; 2017 Apr; 39(4):639-646. PubMed ID: 28236349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of Time to Treatment and Survival Among Adults Younger Than 50 Years of Age With Colorectal Cancer in Canada.
    Castelo M; Paszat L; Hansen BE; Scheer AS; Faught N; Nguyen L; Baxter NN
    JAMA Netw Open; 2023 Aug; 6(8):e2327109. PubMed ID: 37535356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association Between Lymph Node Ratio and Recurrence and Survival Outcomes in Patients With Oral Cavity Cancer.
    Ding D; Stokes W; Eguchi M; Hararah M; Sumner W; Amini A; Goddard J; Somerset H; Bradley C; McDermott J; Raben D; Karam SD
    JAMA Otolaryngol Head Neck Surg; 2019 Jan; 145(1):53-61. PubMed ID: 30452499
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of Early Recurrence Prior to Planned Postoperative Radiation Therapy for Oral Cavity Squamous Cell Carcinoma and Outcomes Following Salvage Intensified Radiation Therapy.
    Hosni A; Huang SH; Chiu K; Xu W; Su J; Bayley A; Bratman SV; Cho J; Giuliani M; Kim J; O'Sullivan B; Ringash J; Waldron J; Spreafico A; Yu E; de Almeida JR; Monteiro E; Chepeha DB; Irish JC; Goldstein DP; Hope A
    Int J Radiat Oncol Biol Phys; 2019 Feb; 103(2):363-373. PubMed ID: 30244160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Compliance With Process-Related Quality Metrics and Improved Survival in Oral Cavity Squamous Cell Carcinoma.
    Graboyes EM; Gross J; Kallogjeri D; Piccirillo JF; Al-Gilani M; Stadler ME; Nussenbaum B
    JAMA Otolaryngol Head Neck Surg; 2016 May; 142(5):430-7. PubMed ID: 26869135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Time between Surgery and Adjuvant Therapy with Survival in Oral Cavity Cancer.
    Chen MM; Harris JP; Orosco RK; Sirjani D; Hara W; Divi V
    Otolaryngol Head Neck Surg; 2018 Jun; 158(6):1051-1056. PubMed ID: 29313448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Timing of postoperative radiation therapy and survival in resected salivary gland cancers: Long-term results from a single institution.
    Romine PE; Voutsinas J; Wu V; Tratt M; Liao J; Parvathaneni U; Barber B; Dillon J; Timoshchuk MA; Futran N; Houlton J; Laramore G; Martins R; Eaton KD; Rodriguez C
    Oral Oncol; 2021 Dec; 123():105626. PubMed ID: 34801976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neighborhood-Level Disadvantage and Delayed Adjuvant Therapy in Head and Neck Cancer.
    Graboyes EM; Cagle JL; Ramadan S; Prasad K; Yan F; Pearce J; Mazul AL; Anoma JS; Hill EG; Chera BS; Puram SV; Jackson R; Sandulache VC; Tam S; Topf MC; Kahmke R; Osazuwa-Peters N; Nussenbaum B; Alberg AJ; Sterba KR; Halbert CH
    JAMA Otolaryngol Head Neck Surg; 2024 Apr; ():. PubMed ID: 38662392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Postoperative Radiation Therapy in Oral Cavity Verrucous Carcinoma.
    Naik AN; Silverman DA; Rygalski CJ; Zhao S; Brock G; Lin C; Puram SV; Rocco JW; Baliga S; VanKoevering KK; Old MO; Seim NB; Kang SY
    Laryngoscope; 2022 Oct; 132(10):1953-1961. PubMed ID: 34989407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in Postoperative Intensity-Modulated Radiation Therapy Use and Its Association With Survival Among Patients With Incompletely Resected Non-Small Cell Lung Cancer.
    Yu B; Jun Ma S; Waldman O; Dunne-Jaffe C; Chatterjee U; Turecki L; Gill J; Yendamuri K; Iovoli A; Farrugia M; Singh AK
    JAMA Netw Open; 2022 Sep; 5(9):e2230704. PubMed ID: 36074462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rates of Occult Invasive Disease in Patients With Biopsy-Proven Oral Cavity Squamous Cell Carcinoma in Situ.
    Cooper DJ; Ziemba Y; Pereira L; Kann BH; Parashar B; Miles BA; Ghaly M; Seetharamu N; Frank D; Talcott WJ
    JAMA Otolaryngol Head Neck Surg; 2024 Feb; 150(2):151-156. PubMed ID: 38175664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical Outcomes in Elderly Patients Treated for Oral Cavity Squamous Cell Carcinoma.
    Chen JJ; Shah JL; Harris JP; Bui TT; Schaberg K; Kong CS; Kaplan MJ; Divi V; Schoppy D; Le QT; Hara WY
    Int J Radiat Oncol Biol Phys; 2017 Jul; 98(4):775-783. PubMed ID: 28602409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of Postoperative Radiotherapy With Survival in Patients With N1 Oral Cavity and Oropharyngeal Squamous Cell Carcinoma.
    Chen MM; Harris JP; Hara W; Sirjani D; Divi V
    JAMA Otolaryngol Head Neck Surg; 2016 Dec; 142(12):1224-1230. PubMed ID: 27832255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of Adjuvant Hormone Therapy Timing With Overall Survival Among Patients With Hormone Receptor-Positive Human Epidermal Growth Factor Receptor-2-Negative Early Breast Cancer Without Chemotherapy.
    Fu F; Yu L; Zeng B; Chen M; Guo W; Chen L; Lin Y; Hou J; Li J; Li Y; Li S; Chen X; Zhang W; Jin X; Cai W; Zhang K; Chen H; Qiu Y; Nie Q; Wang C; Jacobs L
    JAMA Netw Open; 2022 Feb; 5(2):e2145934. PubMed ID: 35166783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment Factors Associated With Survival in Early-Stage Oral Cavity Cancer: Analysis of 6830 Cases From the National Cancer Data Base.
    Luryi AL; Chen MM; Mehra S; Roman SA; Sosa JA; Judson BL
    JAMA Otolaryngol Head Neck Surg; 2015 Jul; 141(7):593-8. PubMed ID: 25974757
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment Outcomes for T4 Oropharyngeal Squamous Cell Carcinoma.
    Zenga J; Wilson M; Adkins DR; Gay HA; Haughey BH; Kallogjeri D; Michel LS; Paniello RC; Rich JT; Thorstad WL; Nussenbaum B
    JAMA Otolaryngol Head Neck Surg; 2015 Dec; 141(12):1118-27. PubMed ID: 25902372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.